These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2055558

  • 21. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
    Hauert J, Nicoloso G, Schleuning WD, Bachmann F, Schapira M.
    Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
    [Abstract] [Full Text] [Related]

  • 22. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA, Rothschild Z, Griffin JH.
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [Abstract] [Full Text] [Related]

  • 23. Factor-XII congenital deficiency. A new family study.
    Lucia JF, Ercoreca L, Torres M, Giralt M, Raichs A.
    Thromb Haemost; 1979 Oct 31; 42(3):1009-17. PubMed ID: 505391
    [Abstract] [Full Text] [Related]

  • 24. Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood.
    Kluft C, Jie AF, Allen RA.
    Thromb Haemost; 1983 Aug 30; 50(2):518-23. PubMed ID: 6356452
    [Abstract] [Full Text] [Related]

  • 25. The contact-system dependent plasminogen activator from human plasma: identification and characterization.
    Binnema DJ, Dooijewaard G, van Iersel JJ, Turion PN, Kluft C.
    Thromb Haemost; 1990 Nov 30; 64(3):390-7. PubMed ID: 2128968
    [Abstract] [Full Text] [Related]

  • 26. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A, Ling RJ, Sutton PM, Griffiths B, Riley PA, Atkinson T.
    Thromb Haemost; 1985 Apr 22; 53(2):200-3. PubMed ID: 4040659
    [Abstract] [Full Text] [Related]

  • 27. Fibrinolytic properties of activated FXII.
    Braat EA, Dooijewaard G, Rijken DC.
    Eur J Biochem; 1999 Aug 22; 263(3):904-11. PubMed ID: 10469157
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M.
    Wien Med Wochenschr; 1993 Jun 30; 143(2):43-50. PubMed ID: 8488686
    [Abstract] [Full Text] [Related]

  • 33. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI.
    J Clin Invest; 1979 Oct 30; 64(4):1056-65. PubMed ID: 479368
    [Abstract] [Full Text] [Related]

  • 34. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan 30; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S.
    Crit Care Med; 2003 Apr 30; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [Abstract] [Full Text] [Related]

  • 38. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T, Castellino FJ.
    Thromb Haemost; 2006 Jun 30; 95(6):1003-10. PubMed ID: 16732380
    [Abstract] [Full Text] [Related]

  • 39. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that two of 49 subjects are cross-reacting material positive (CRM+).
    Saito H, Scott JG, Movat HZ, Scialla SJ.
    J Lab Clin Med; 1979 Aug 30; 94(2):256-65. PubMed ID: 110893
    [Abstract] [Full Text] [Related]

  • 40. Fletcher factor deficiency (Report of a new case).
    Colla G, Carrea M, Sbaffi A.
    Ric Clin Lab; 1983 Aug 30; 13(4):443-8. PubMed ID: 6558774
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.